Gambetta RA[au] - Search Results

Year	Number of Results
1971	2
1972	1
1980	1
1981	1
1983	1
1986	2
1988	1
1989	2
1991	1
1992	2
1993	2
1994	3
1995	2
1996	1
1997	1
1998	1
2000	2
2022	0

1

The interaction of daunorubicin and doxorubicin with DNA and chromatin.

Zunino F, Di Marco A, Zaccara A, Gambetta RA. Zunino F, et al. Among authors: gambetta ra. Biochim Biophys Acta. 1980 Apr 30;607(2):206-14. doi: 10.1016/0005-2787(80)90073-8. Biochim Biophys Acta. 1980. PMID: 7370266

2

Changes in the three-dimensional organization of LoVo cells associated with resistance to doxorubicin.

Soranzo C, Ingrosso A, Buffa M, Della Torre G, Gambetta RA, Zunino F. Soranzo C, et al. Among authors: gambetta ra. Cancer Lett. 1989 Nov 15;48(1):37-41. doi: 10.1016/0304-3835(89)90200-0. Cancer Lett. 1989. PMID: 2819694

3

Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative.

Lanzi C, Cassinelli G, Pensa T, Cassinis M, Gambetta RA, Borrello MG, Menta E, Pierotti MA, Zunino F. Lanzi C, et al. Among authors: gambetta ra. Int J Cancer. 2000 Feb 1;85(3):384-90. Int J Cancer. 2000. PMID: 10652431 Free article.

4

Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin.

Cassinelli G, Lanzi C, Pensa T, Gambetta RA, Nasini G, Cuccuru G, Cassinis M, Pratesi G, Polizzi D, Tortoreto M, Zunino F. Cassinelli G, et al. Among authors: gambetta ra. Biochem Pharmacol. 2000 Jun 15;59(12):1539-47. doi: 10.1016/s0006-2952(00)00278-1. Biochem Pharmacol. 2000. PMID: 10799650

5

Lack of effect of glutathione depletion on cytotoxicity, mutagenicity and DNA damage produced by doxorubicin in cultured cells.

Capranico G, Babudri N, Casciarri G, Dolzani L, Gambetta RA, Longoni E, Pani B, Soranzo C, Zunino F. Capranico G, et al. Among authors: gambetta ra. Chem Biol Interact. 1986 Feb;57(2):189-201. doi: 10.1016/0009-2797(86)90037-2. Chem Biol Interact. 1986. PMID: 3955790

6

MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistance.

Binaschi M, Supino R, Gambetta RA, Giaccone G, Prosperi E, Capranico G, Cataldo I, Zunino F. Binaschi M, et al. Among authors: gambetta ra. Int J Cancer. 1995 Jul 4;62(1):84-9. doi: 10.1002/ijc.2910620116. Int J Cancer. 1995. PMID: 7601572

7

Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance.

Lanzi C, Perego P, Supino R, Romanelli S, Pensa T, Carenini N, Viano I, Colangelo D, Leone R, Apostoli P, Cassinelli G, Gambetta RA, Zunino F. Lanzi C, et al. Among authors: gambetta ra. Biochem Pharmacol. 1998 Apr 15;55(8):1247-54. doi: 10.1016/s0006-2952(97)00599-6. Biochem Pharmacol. 1998. PMID: 9719480

8

The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.

Banfi P, Lanzi C, Falvella FS, Gariboldi M, Gambetta RA, Dragani TA. Banfi P, et al. Among authors: gambetta ra. Mol Pharmacol. 1994 Nov;46(5):896-900. Mol Pharmacol. 1994. PMID: 7969077

9

Protein kinase C activation and lipid peroxidation by doxorubicin analogues.

Gambetta RA, Banfi P, Lanzi C, Franzi A, Zunino F. Gambetta RA, et al. Tumori. 1989 Aug 31;75(4):358-61. doi: 10.1177/030089168907500411. Tumori. 1989. PMID: 2815343

10

Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity.

Di Marco A, Zunino F, Silverstrini R, Gambarucci C, Gambetta RA. Di Marco A, et al. Among authors: gambetta ra. Biochem Pharmacol. 1971 Jun;20(6):1323-8. doi: 10.1016/0006-2952(71)90365-0. Biochem Pharmacol. 1971. PMID: 5165732 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results